Commentary: The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study
Neurosurgery
.
2020 Sep 1;87(3):E301-E302.
doi: 10.1093/neuros/nyaa123.
Authors
Jean Régis
1
,
Constantin Tuleasca
2
3
4
,
John W Hopewell
5
,
Frederic Castinetti
6
7
Affiliations
1
Functional and Stereotaxic Neurosurgery Service and Gamma Knife Unit, Centre Hospitalier Universitaire "La Timone," Marseille, France.
2
Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
3
University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland.
4
Signal Processing Laboratory (LTS 5), Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
5
Green Templeton College, University of Oxford, Oxford, United Kingdom.
6
Inserm, MMG, Aix-Marseille University, Marseille, France.
7
Endocrinology Department, CHU Conception, Aix-Marseille University, Marseille, France.
PMID:
32348481
DOI:
10.1093/neuros/nyaa123
No abstract available
Publication types
Comment
MeSH terms
Acromegaly* / surgery
Cohort Studies
Humans
Pituitary Neoplasms* / surgery
Radiosurgery* / adverse effects
Somatomedins*
Substances
Somatomedins